How common is childhood cancer? — incidence, rarity & what it means for your family

Childhood cancer is uncommon but not rare — it is consistently one of the leading causes of disease-related death among children beyond infancy in India, and the numbers have been rising as reporting improves. India's national cancer registries (ICMR-NCRP) record tens of thousands of new childhood cancer diagnoses each year, with leukaemia, brain tumours, and lymphomas accounting for the majority. The incidence per lakh children is lower than in Western countries, but India's large population means the absolute number of children affected is substantial. Because many cases are first seen in district hospitals that do not refer to specialist centres, real incidence is likely under-counted. Early diagnosis and referral to a specialist paediatric oncology team remain the most important steps a family can take.

The observed increase in recorded childhood cancer cases in India largely reflects better diagnosis and reporting rather than a true rise in incidence. As more hospitals perform biopsies, molecular tests, and imaging in children, more cases that previously went undiagnosed or were attributed to other causes are now correctly identified as cancer. Global data from high-income countries — where reporting has been consistent for decades — show that childhood cancer incidence has been broadly stable, though modest real increases have been observed in certain tumour types. What has changed dramatically is the outcome: survival rates for many childhood cancers have improved significantly over recent decades because of advances in treatment protocols and multi-disciplinary care.

Acute leukaemia — particularly acute lymphoblastic leukaemia (ALL) — is the most common childhood cancer worldwide and in India, accounting for roughly one-third of all paediatric cancer diagnoses. After leukaemia, brain and central nervous system tumours are the second most common category, followed by lymphomas (Hodgkin and non-Hodgkin). Together, these three groups account for more than half of all childhood cancers. The remaining cases include solid tumours such as Wilms tumour of the kidney, neuroblastoma of the adrenal gland, retinoblastoma of the eye, bone cancers (osteosarcoma, Ewing sarcoma), and soft-tissue sarcomas. A paediatric oncologist will tell you which type your child has and what that means for treatment.

Childhood cancer is significantly rarer than adult cancer. Adults develop cancer at rates many times higher than children, and more than 95% of all new cancer diagnoses in India occur in people over the age of 20. However, "rare" does not mean "untreatable." Childhood cancers are biologically distinct from adult cancers of the same name — they often grow faster but also respond more dramatically to treatment. Several types that were nearly always fatal just a few decades ago now have very high survival rates with modern protocols. The rarity of childhood cancer is one reason specialist paediatric oncology teams are important: these teams see enough cases to maintain expertise and to follow international treatment guidelines precisely.

The peak ages for childhood cancer diagnosis vary by cancer type. Leukaemia peaks between the ages of two and five years. Brain tumours can occur at any childhood age but cluster in the early school years. Neuroblastoma is most common in infants and toddlers under five. Retinoblastoma typically presents before the age of five, often in the first two to three years of life. Lymphomas and bone cancers are more frequent in older children and adolescents. Wilms tumour most commonly affects children between three and four years of age. Knowing the age patterns can help parents and paediatricians keep childhood cancer on the differential when a child presents with persistent, unexplained symptoms.

Most children with symptoms like fatigue, a lump, or unexplained weight loss do not have cancer — far more common explanations exist for each of these signs. However, childhood cancer is more treatable when found early, so any symptom that is persistent, progressive, or unexplained for more than two to four weeks deserves a proper evaluation by a paediatrician and, if needed, referral to a specialist. At CION Cancer Clinics, your child's case is reviewed with a 45-minute consultation and a tumour board approach — we do not rush the assessment or order unnecessary tests. If cancer is found, we walk this journey with you from the very first appointment. If it is not cancer, we give you a clear explanation of what else is going on.